A synthetic Antrodia cinnamomea galactomannan library by frameshift unveils a potent immunoregulatory octasaccharide domain
Science Advances · 2026
DOI: 10.1126/sciadv.aec5309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Qishuai Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs of Ministry of Education, Shandong Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy…. Hauptthemen laut MEDLINE: Mannans, Oligosaccharides, Antrodia, Frameshift Mutation. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Health -Singapore, National Natural Science Foundation of China, Marine S&T Fund of Shandong Province for Pilot National Laboratory for Marine Science and Technology.
Abstract (Originalsprache)
We report the design, synthesis, and immunological evaluation of an Antrodia cinnamomea galactomannan library consisting of 11 oligosaccharides, with chain lengths ranging from 4 to 24 sugars. These oligosaccharides maintain a consistent composition of 75% mannose and 25% galactose, mirroring the key structural features of natural galactomannan. Notably, the library includes five tetrasaccharides and four octasaccharides, exhibiting all possible frameshift patterns of A. cinnamomea galactomannan, offering valuable materials for structure-activity relationship studies to explore the role of linking modes and domain effect. The synthesis of this library was achieved through a highly effective stereoselective α-galactosylation approach. Immunological evaluations revealed that octasaccharide 4 and its two subunit tetrasaccharides 7 and 10 exhibited potent immunoregulatory activities, demonstrating a notable domain effect. Preliminary mechanistic studies unveiled that these oligosaccharides exert their effects by suppressing mitogen-activated protein kinase signaling pathway. In addition, octasaccharide 4 uniquely attenuated nuclear factor κB pathway, highlighting its compound-specific mechanism and demonstrating a 1 + 1 > 2 effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs of Ministry of Education, Shandong Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, Shandong 266237, China.
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.
ORCID-Profile: Qishuai Li, Xiao-Lin Zhang, Ran Liu, Hongzhi Cao, Allan Wee Ren Ng, Yuan Qiao, Han Ding, Xue-Wei Liu, Ming Li
Förderung
- Ministry of Health -Singapore
- National Natural Science Foundation of China
- Marine S&T Fund of Shandong Province for Pilot National Laboratory for Marine Science and Technology
- National Key Research & Development Program of China
- Health and Medical Research Fund
- Nanyang Technological University
- National Research Foundation-Prime Minister's office, Republic of Singapore
- Ocean University of China and Shandong Science and Technology Fund
Zitieren
APA
Li, Q., Zhang, X. L., Liu, R., Wang, P., Cao, H., Ng, A. W. R., Qiao, Y., Ding, H., Liu, X. W., & Li, M. (2026). A synthetic Antrodia cinnamomea galactomannan library by frameshift unveils a potent immunoregulatory octasaccharide domain. Science Advances. https://doi.org/10.1126/sciadv.aec5309
Vancouver
Li Q, Zhang XL, Liu R, Wang P, Cao H, Ng AWR, et al. A synthetic Antrodia cinnamomea galactomannan library by frameshift unveils a potent immunoregulatory octasaccharide domain. Science Advances. 2026. doi:10.1126/sciadv.aec5309
BibTeX
@article{Li2026,
author = {Li, Qishuai and Zhang, Xiao-Lin and Liu, Ran and Wang, Peng and Cao, Hongzhi and Ng, Allan Wee Ren and Qiao, Yuan and Ding, Han and Liu, Xue-Wei and Li, Ming},
title = {A synthetic Antrodia cinnamomea galactomannan library by frameshift unveils a potent immunoregulatory octasaccharide domain},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aec5309}
}
EUVIMED